The Common C49620T Polymorphism in the Sulfonylurea Receptor Gene SUR1 (ABCC8) in Patients with Gestational Diabetes and Subsequent Glucose Metabolism Abnormalities

<div class="floats-full-page floats-full-page-other"><h2>Table 3</h2><div class="floats-full-page-caption">Polymorphism C49620T in the SUR1 (ABCC8) gene distribution.</div><div class="floats-full-page-content"><table class="table-group" id="tab3"><tr><td><table class="table"><tr><td class="thead-hr" colspan="4"><hr /></td></tr><tr class="thead"><td align="left"></td><td align="center">GDM (+) <i>n</i> = 199 (%)</td><td align="center">GDM (−) <i>n</i> = 50 (%)</td><td align="center"><i>P</i> value</td></tr><tr><td class="thead-hr" colspan="4"><hr /></td></tr><tr><td align="left">CC</td><td align="center">54 (27.14%)</td><td align="center">14 (28.0%)</td><td align="center">NS</td></tr><tr><td align="left">CT</td><td align="center">96 (48.24%)</td><td align="center">22 (44.0%)</td><td align="center">NS</td></tr><tr><td align="left">TT</td><td align="center">49 (24.62%)</td><td align="center">14 (28.0%)</td><td align="center">NS</td></tr><tr><td align="left">C allel carriers</td><td align="center">204 (51.3%)</td><td align="center">50 (50.0%)</td><td align="center">NS</td></tr><tr><td align="left">T allel carriers</td><td align="center">194 (48.7%)</td><td align="center">50 (50.0%)</td><td align="center">NS</td></tr><tr class="table-tr"><td colspan="4"><hr class="tbody-hr" /></td></tr></table></td></tr></table></div></div>

Table 3 | The Common C49620T Polymorphism in the Sulfonylurea Receptor Gene SUR1 (ABCC8) in Patients with Gestational Diabetes and Subsequent Glucose Metabolism Abnormalities

title

Table 3: The Common C49620T Polymorphism in the Sulfonylurea Receptor Gene SUR1 (ABCC8) in Patients with Gestational Diabetes and Subsequent Glucose Metabolism Abnormalities

description

Table 3

About this journal

<p><em>Journal of Diabetes Research</em> publishes articles related to type 1 and type 2 diabetes. Topics include etiology, pathogenesis, management, and prevention of diabetes, as well as associated complications such as nephropathy.</p>


Journal profile

Meet the editorial board

<p>Chief Editor Dr Mark Yorek, from the University of Iowa, is currently researching vascular and neural disease related to obesity and diabetes. His active research studies focus on etiology, treatment and prevention of nerve damage.</p>


Editor spotlight

Submit to Special Issue

We currently have a number of Special Issues open for submission. Special Issues highlight emerging areas of research within a field, or provide a venue for a deeper investigation into an existing research area.